Poggetto John Dal serves as Executive at Sonoma Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Poggetto John Dal has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 20, 2024 involved receiving (via award) 15,000 shares valued at $0.
Poggetto John Dal currently holds 15,000 shares of Sonoma Pharmaceuticals, Inc. (SNOA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Poggetto John Dal has been a net neutral trader of SNOA stock. They have purchased $0 and sold $0 worth of shares.
Poggetto John Dal's most recent insider trade was on Jun 20, 2024, when they sold 15,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |